- Home
- AMPG vs MAIA Comparison
AMPG vs MAIA Comparison
Compare AMPG & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPG
- MAIA
- Stock Information
- Founded
- AMPG 2002
- MAIA 2018
- Country
- AMPG United States
- MAIA United States
- Employees
- AMPG N/A
- MAIA N/A
- Industry
- AMPG Telecommunications Equipment
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- AMPG Telecommunications
- MAIA Health Care
- Exchange
- AMPG Nasdaq
- MAIA Nasdaq
- Market Cap
- AMPG 46.7M
- MAIA 46.7M
- IPO Year
- AMPG N/A
- MAIA 2022
- Fundamental
- Price
- AMPG $2.10
- MAIA $1.74
- Analyst Decision
- AMPG Strong Buy
- MAIA
- Analyst Count
- AMPG 1
- MAIA 0
- Target Price
- AMPG $5.00
- MAIA N/A
- AVG Volume (30 Days)
- AMPG 185.6K
- MAIA 421.3K
- Earning Date
- AMPG 08-13-2025
- MAIA 08-08-2025
- Dividend Yield
- AMPG N/A
- MAIA N/A
- EPS Growth
- AMPG N/A
- MAIA N/A
- EPS
- AMPG N/A
- MAIA N/A
- Revenue
- AMPG $10,814,140.00
- MAIA N/A
- Revenue This Year
- AMPG $114.55
- MAIA N/A
- Revenue Next Year
- AMPG $50.00
- MAIA N/A
- P/E Ratio
- AMPG N/A
- MAIA N/A
- Revenue Growth
- AMPG N/A
- MAIA N/A
- 52 Week Low
- AMPG $0.64
- MAIA $1.40
- 52 Week High
- AMPG $6.43
- MAIA $4.24
- Technical
- Relative Strength Index (RSI)
- AMPG 51.21
- MAIA 47.75
- Support Level
- AMPG $1.89
- MAIA $1.66
- Resistance Level
- AMPG $2.08
- MAIA $1.95
- Average True Range (ATR)
- AMPG 0.12
- MAIA 0.12
- MACD
- AMPG -0.02
- MAIA -0.00
- Stochastic Oscillator
- AMPG 39.22
- MAIA 31.82
About AMPG Amplitech Group Inc.
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.